Clinical Evaluation of the Origin Intubation System (NCT07189182) | Clinical Trial Compass
Not Yet RecruitingEarly Phase 1
Clinical Evaluation of the Origin Intubation System
United States15 participantsStarted 2026-09-01
Plain-language summary
There are currently two options that are utilized are artificial airways in the operating room as well in emergency medicine: the endotracheal tube and the supraglottic airway. However, with these devices, healthcare professionals often experience difficulty and/or failure in utilizing these devices during their first-pass at intubation. Additionally, military medics often forego intubation in favor of basic life support during prolonged resuscitation. This study aims to test a device, one that has been tested in over 100 cadavers, to determine if it is a viable and safer/more successful option for intubation.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Male or Female subjects 18 years of age or older and less than 75.
✓. English or Spanish Speaking.
✓. Undergoing elective surgery requiring endotracheal intubation.
✓. Use of general anesthesia.
Exclusion criteria
✕. Patients with high aspiration risk.
✕. Inability to provide informed consent in English or Spanish
✕. Patients for whom an awake intubation is indicated and planned.
✕. Patients with a history of head and neck radiation.